National Research Corporation

    Jurisdiction
    United States
    LEI
    549300FQIORB6GZCYT15
    ISIN
    US6373722023 (NRC)
    Sectors
    1. Healthcare
    2. Medical - Healthcare Information Services

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Read full profile

    Fundamentals

    Net revenue
    €119.68M
    Gross margin
    58.0%
    EBIT
    €23.67M
    EBIT margin
    19.8%
    Net income
    €15.29M
    Net margin
    12.8%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.12
    Ex date
    Payment date
    Dividend payout ratio
    62.4%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Freeman Jordan Nicole Chief Accounting Officer +771 $12.97 +$10.00K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 370K $4.74M -34K Sell

    Earnings Calls

    Latest earnings call: May 8, 2024 (Q1 2024)

    Add to watchlist

    Notifications